-

11:52:52 PM

SOPH Stock News

SOPH - SOPHiA Genetics SA

01/11/22 7:27 AM

Nasdaq : SOPH

clinical trial

SOPHiA GENETICS Reports Strong Traction in the Launch Phase of its DEEP-Lung-IV Multimodal Clinical Study

SOPHiA GENETICS SA (NASDAQ: SOPH), the creator of a global data pooling and knowledge sharing platform that advances data-driven medicine, announced today strong traction in the launch phase of their DEEP-Lung-IV clinical study

RHEA-AI

neutral

01/10/22 7:28 AM

Nasdaq : SOPH

management

Executive Team Hires at SOPHiA GENETICS to Enhance BioPharma Business

SOPHiA GENETICS SA (Nasdaq: SOPH), the creator of a global data pooling and knowledge sharing platform that advances data-driven medicine, announced key additions to their leadership team with the hiring of Peter Casasanto as Chief

RHEA-AI

very positive

12/29/21 7:00 AM

Nasdaq : SOPH

conferences

SOPHiA GENETICS to Present at the 40th Annual J.P. Morgan Healthcare Conference

SOPHiA GENETICS SA (Nasdaq: SOPH), announced today Chief Executive Officer and Co-Founder Dr. Jurgi Camblong and Chief Financial Officer Ross Muken, will participate in the upcoming 40 th Annual J.P. Morgan Healthcare Conference.

RHEA-AI

neutral

12/01/21 9:24 AM

Nasdaq : SOPH

clinical trial

SOPHiA GENETICS Announces Launch of DEEP-Lung-IV Multimodal Clinical Study

Study to leverage deep learning-enabled analysis of the aggregation of real-world multimodal data to validate predictive signatures associated with response to immunotherapy and prognosis of patients with stage IV non-small cell lung cancerLarge-scale, multicentric real-world study aims to enroll

RHEA-AI

neutral

11/29/21 10:32 AM

Nasdaq : SOPH

SOPHiA GENETICS Hosts Symposium with GE Healthcare at RSNA 2021

Symposium to address how new AI-powered analytic and workflow solutions for clinical and biopharma markets are advancing data-driven medicineSymposium encapsulates SOPHiA GENETICS and GE Healthcare alliance to provide joint solutions and multimodal analytics to healthcare providers and biopharma

RHEA-AI

very positive

11/17/21 3:00 AM

Nasdaq : FLYW, TLND, SOPH

Balderton Capital Raises New $600m Early-stage Fund to Back Europe’s Next Wave of Breakout Tech

Balderton Capital has raised its second fund of 2021– a $600 m fund focused on early-stage companies– to support its mission to be the leading provider of venture capital and founder support to European startups with global ambitions. Companies where Balderton invested at Seed or Series A, include Aircall, Beauty Pie, ComplyAdvantage, Contentful, Depop, Dream...

RHEA-AI

very positive

11/10/21 7:00 AM

Nasdaq : SOPH

earnings

SOPHiA GENETICS Reports Third Quarter 2021 Financial Results and Raises 2021 Guidance

SOPHiA GENETICS SA (Nasdaq: SOPH), today reported financial results for the third quarter ended September 30, 2021. Recent

RHEA-AI

very positive

11/01/21 8:03 AM

Nasdaq : SOPH

SOPHiA GENETICS Launches SOPHiA DDM™ for SureSelect Human All Exon v8

SOPHiA GENETICS SA (Nasdaq: SOPH), the creator of a global data pooling and knowledge sharing platform that advances data-driven

RHEA-AI

very positive

10/28/21 4:05 PM

Nasdaq : SOPH

conferences

SOPHiA GENETICS to Participate in Upcoming November Investor Conferences

SOPHiA GENETICS SA (Nasdaq: SOPH) today announced the company will be participating virtually in the following investor conferences: Credit Suisse 30th Annual Healthcare Conference; Fireside Chat on Thursday, November 11 th at

RHEA-AI

neutral

10/27/21 4:05 PM

Nasdaq : SOPH

conferencesearnings

SOPHiA GENETICS to Report Third Quarter 2021 Financial Results on November 10, 2021

SOPHiA GENETICS SA (Nasdaq: SOPH) today announced it will report financial results for the third quarter of 2021 before market open on Wednesday, November 10, 2021. The company’s management will webcast a corresponding conference

RHEA-AI

neutral